Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
Duchenne muscular dystrophy is a severe muscle-wasting disease caused by mutations in the dystrophin gene that ablate functional protein expression. Although exonic deletions are the most common Duchenne muscular dystrophy lesion, duplications account for 10-15% of reported disease-causing mutations...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Book |
Published: |
Elsevier,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_4851980feaf64c7490bb8f380cf6e7f5 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Kane L Greer |e author |
700 | 1 | 0 | |a Hanns Lochmüller |e author |
700 | 1 | 0 | |a Kevin Flanigan |e author |
700 | 1 | 0 | |a Susan Fletcher |e author |
700 | 1 | 0 | |a Steve D Wilton |e author |
245 | 0 | 0 | |a Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene |
260 | |b Elsevier, |c 2014-01-01T00:00:00Z. | ||
500 | |a 2162-2531 | ||
500 | |a 10.1038/mtna.2014.8 | ||
520 | |a Duchenne muscular dystrophy is a severe muscle-wasting disease caused by mutations in the dystrophin gene that ablate functional protein expression. Although exonic deletions are the most common Duchenne muscular dystrophy lesion, duplications account for 10-15% of reported disease-causing mutations, and exon 2 is the most commonly duplicated exon. Here, we describe the in vitro evaluation of phosphorodiamidate morpholino oligomers coupled to a cell-penetrating peptide and 2'-O-methyl phosphorothioate oligonucleotides, using three distinct strategies to reframe the dystrophin transcript in patient cells carrying an exon 2 duplication. Differences in exon-skipping efficiencies in vitro were observed between oligomer analogues of the same sequence, with the phosphorodiamidate morpholino oligomer coupled to a cell-penetrating peptide proving the most effective. Differences in exon 2 excision efficiency between normal and exon 2 duplication cells, were apparent, indicating that exon context influences oligomer-induced splice switching. Skipping of a single copy of exon 2 was induced in the cells carrying an exon 2 duplication, the simplest strategy to restore the reading frame and generate a normal dystrophin transcript. In contrast, multiexon skipping of exons 2-7 to generate a Becker muscular dystrophy-like dystrophin transcript was more challenging and could only be induced efficiently with the phosphorodiamidate morpholino oligomer chemistry. | ||
546 | |a EN | ||
690 | |a antisense oligomers | ||
690 | |a Duchenne muscular dystrophy | ||
690 | |a duplication mutations | ||
690 | |a dystrophin | ||
690 | |a exon skipping | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Molecular Therapy: Nucleic Acids, Vol 3, Iss C (2014) | |
787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2162253116302955 | |
787 | 0 | |n https://doaj.org/toc/2162-2531 | |
856 | 4 | 1 | |u https://doaj.org/article/4851980feaf64c7490bb8f380cf6e7f5 |z Connect to this object online. |